-+ 0.00%
-+ 0.00%
-+ 0.00%

Cepheid wins FDA clearance for Xpert Respiratory Panel multiplex PCR test

PUBT·09/29/2026 13:05:42
Listen to the news
Cepheid wins FDA clearance for Xpert Respiratory Panel multiplex PCR test
  • Cepheid, a Danaher unit, received FDA clearance for its Xpert Respiratory Panel multiplex PCR test for suspected respiratory tract infections.
  • Test detects 13 common viral and bacterial pathogens from a single nasopharyngeal swab on existing GeneXpert systems.
  • U.S. shipments are set to start in the coming weeks, expanding Cepheid’s respiratory testing menu on the GeneXpert platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609290900PR_NEWS_USPR_____LA58753) on September 29, 2026, and is solely responsible for the information contained therein.